Background and purpose: To assess the effect of differences in the calculation of the dose outside segment edges on the overall dose distribution and the optimisation process of intensity modulated radiation therapy (IMRT) treatment plans.
Introduction
Intensity-modulated radiation therapy (IMRT) aims at improving the target coverage and/or the sparing of organs at risk, by allowing better control of the fluence delivered from a given beam portal compared to more traditional techniques [1, 6, 8, 9, 19, 27, 31] . However, this improvement comes at a cost, which is an increased treatment complexity, from planning to verification of its delivery [11, 20, 21, 24, 30] . Concerning the treatment planning aspects, IMRT is different from conventional techniques, with respect to both the irradiation patterns (i.e. shape and number of segments) and the way they are defined (i.e. through a computer-based process rather than a manual one). For a given gantry angle, intensity modulation is often obtained with a non-intuitive combination of segment shapes and weights. Also, the classical concept of defining a beam aperture in such a way that the target is always in the open part of the segment while the surrounding tissues are as much as possible shielded by the jaws, or the leaves of an MLC, is often abandoned. In IMRT treatments, both the target volumes and the organs at risk can be, for a specific segment, in the high-dose region, in the penumbra or outside the geometric edges of the segment itself. From the point of view of dose calculation, such an approach requires that the algorithm is able to properly handle these different situations if a correct 3D dose evaluation is needed. Moreover, IMRT segment weights and/or segment shapes are defined through a computerized approach that relies on a cost function to rate different solutions. This cost function is often expressed in terms of dose -volume histograms (DVH) points or other parameters in dose or volume space (e.g. the mean dose). If a parameter of the cost function is defined in a region of the dose space where the dose is not accurately predicted, the whole optimisation process will be biased.
The difficulty in calculating the dose outside the geometrical edges of the segment was recently recognized in a publication on the accuracy requirements for the dose calculation algorithms [28] . Here it was noted that, when differences between measurements and calculations are normalized to the local dose value, the actual accuracy achievable with most dose calculation algorithms changes considerably according to the irradiation geometry and the point of measurement. In particular, when the comparisons are carried out in low-dose and low-dose gradient regions (e.g. outside the geometric edges of the segment), the differences between measurements and calculations can be as high as 50% for the more complex situations.
So far, the importance of the accuracy of dose calculation in IMRT plans has been studied mainly with the purpose to assess the need for Monte Carlo-based dose calculations in regions where inhomogeneity corrections play an important role [14, 15, 17, 18] . Recently, a study appeared that analyses the effect of different modelling of the transmission through the jaws for prostate plans [2] . The evaluation was carried out for points in the high-dose region and for onedimensional (1D) profiles, but no estimate of this effect on the 3D total dose distribution for an IMRT plan was given.
Implementation of IMRT has currently a high priority in many centres, and the commissioning of the dose calculation algorithm of new optimisation software is one aspect to be considered. In particular, it is important to identify which additional experimental tests have to be carried out and to assess whether the accuracies required in dose calculation for conventional radiation therapy are also adequate for the safe introduction of IMRT.
In this work, we investigated two treatment planning systems (TPS) that present differences in the calculation of the dose outside segment edges. Measurements in a water phantom were carried out to ensure that both systems fulfil the accuracy criteria of dose calculations as presented in various reports (e.g. [13, 28] ). Dose distributions of patients with tumour of the prostate or in the head and neck region treated with IMRT were calculated with both TPSs with the aim to assess: (a) the impact of differences in dose calculations outside the segment on the 3D dose distribution for the volumes of interest and (b) the effect of dosimetric differences on IMRT plan optimisation.
Methods and materials

IMRT techniques
The IMRT techniques for prostate and head and neck tumours that are currently clinically applied in our centre are based on manual segment definition and subsequent computer-based segment weight optimisation. The TPS used for this purpose is U-MPlan (University of Michigan, Ann Arbor, Michigan), which is called TPS1 in this study.
Prostate treatments are planned with a simultaneous integrated boost (SIB) technique [4] , which is the combination of a 5-beam IMRT 'class-solution' approach [7] together with the simultaneous treatment of the primary PTV (PTV1, with a prescribed dose of 68 Gy) and the boost volume (PTV2, with a prescribed dose of 78 Gy) [4] . A total of twenty-two segments per IMRT plan with a predefined distance between the MLC leaves and the anatomical structures (PTVs and/or the rectal wall) are set in beam's eye-view, after which a computerized segment weight optimisation is run, using a DVH-based cost function. Only segments with more than 4 MUs are retained at the end of the optimisation, and their final number ranges from 8 to 13 for the patients included in this study.
Head and neck treatments concern a parotid sparing technique for patients with larynx or base of the tongue cancer. Segments are defined on a patient-per-patient basis, as the individual anatomical variability has been found to be too complex for a 'class-solution' approach. Patients are usually treated in two phases, one up to 46 Gy where the primary tumour (PTV1) and the left (LFN_L) and right (LFN_R) nodal regions are treated, and a second with a boost of 24 Gy where a smaller volume (PTV2) is treated. In this study we analyse dose distributions related to the first phase only (i.e. up to 46 Gy), as these plans better represent an example of multi-segment IMRT treatment. Segment weights are computer-optimised using a cost function that includes objectives on PTVs, parotid glands and spinal cord (see Appendix A). Objectives are set to ensure proper target coverage and to avoid overdosage, while reducing the dose to organs at risk. For the parotids, the aim is to achieve a mean dose not higher than 26 Gy for the whole treatment, as a strong correlation has been found between mean parotid dose and late side effects [9, 10, 25] . The maximum dose to the spinal cord for the whole treatment must be below 45 Gy. Also for the head and neck case, segments with less than 4 MUs are discarded after the optimisation, and the final plan consists of a number of segments ranging from 11 to 19 for the patients analysed in this work. The contours of volumes of interest for the head and neck cases were chosen not to be too close to air cavities, in order to minimize the problem of different inhomogeneity corrections between the two planning systems in proximity of low density regions. Also, the equivalent field size of most segments is larger than 8 cm 2 , the minimum being 6.4 cm 2 , thus further reducing the importance of air cavities [16, 29] .
Treatment planning systems: tests carried out in phantoms
The second TPS (TPS2) used in our study is Pinnacle (Philips Medical Systems, Best, The Netherlands) version 6.0g. As the system was not used in our centre for calculation of IMRT plans before this study, the following tests carried out in the commissioning of TPS1 for the clinical use of IMRT were repeated: † Comparison between measured and calculated cGy/MU value for 80 segments (53 related to head and neck and 27 to prostate plans) used in IMRT treatments. As the main aim of this test was to evaluate the MU calculation modules of the two systems, the measurements were carried out with an ionisation chamber located at the centre of the segment within a water phantom. The detector was a PinPoint chamber (PTW-Freiburg), a device that has been proven to be suitable for the characterisation of the small segments used in IMRT [23] . † Comparison between measurements and calculations along 1D profiles through the total dose distribution of a prostate plan. The segments used for a prostate treatment were sequentially applied to irradiate a water phantom, and line scans were performed with an ionisation chamber. The directions of the line scans with respect to the segments were such that the sum of all scans corresponds to a 1D scan of the total dose distribution, where the patient shape is approximated to a pentagon-like water phantom (see Damen et al. [7] for details). † Comparison between measurements and calculations along dose profiles for single IMRT segments used in head and neck treatment. † Comparison between measurements and calculations for the total dose at a point for head and neck treatments. In this test, the segments used in the treatment of one patient were applied to a cylindrical phantom made of waterequivalent material, with the same gantry and collimator orientations as used during the clinical treatment. The treatment consisted of 16 segments, four of them delivered with non co-planar beam orientations. We measured the dose delivered by the remaining 12 segments with co-planar beam orientation. Measurements were carried out with an ionisation chamber located at the same position for all segments, in order to evaluate the accuracy of TPS1 and TPS2 for different locations of the point of measurement with respect to the segments. We selected a measurement point in the open part of one segment, while it was outside the geometrical edges of the remaining 11 segments. † In the low-dose gradient regions, the difference between measurements and calculation was defined as
for the dose delivered at a point by a single segment i and by the total number of segments, respectively. The local dose value was considered, for both measurements and calculation. In the high-dose gradient regions we evaluated the difference in mm rather than using Eqs. (1) and (2). The tests we performed should not be considered as an exhaustive evaluation of TPS1 and TPS2 with respect to MLC modelling. Such an approach would require a quantitative evaluation of single aspect, such as the influence of 'tongue-and-groove' effect and the rounded leaf-ends on the dose distribution, which were beyond the purpose of our study. Instead, we focussed our experimental measurements on the assessment of the overall accuracy of the two TPSs in the calculation of dose distributions relative to single segments and to overall irradiation patterns for typical IMRT treatments.
Comparison of dose distributions
The DVH calculation modules of the two systems were tested, by comparing various DVHs with those calculated by an in-house developed algorithm, enabling to handle volumes and doses generated by either TPS1 or TPS2. The results showed that the evaluation of dosimetric differences is not biased by using for each TPS its own DVH module, provided that in TPS2 a 2 mm dose calculation grid is used for head and neck cases.
To compare treatment plans based on CT datasets (five patients with prostate cancer, and five patients with cancer in the head and neck region), a software module was used that converts the files describing images, contours and segment settings from TPS1 to TPS2 format. The plans calculated and optimised in TPS1, and accepted for clinical use, were transferred to TPS2, where for each segment the same number of MUs as calculated by TPS1 was applied.
Point dose values
A comparison between TPS1 and TPS2 was carried out at selected points in CT scans. From three treatment plans of head and neck patients and four plans in the prostate region, 40 points were selected (20 for each site). Both the dose delivered by each segment and the position of the point with respect to the segment were recorded. In total, 345 segments were analyzed. A point was considered to be inside a segment if the dose received from the segment was at least 50% of the dose received by another point located in the centre of the segment and at the same depth as the point under analysis.
For both treatment sites, the points were selected in such a way that they were within the volumes used in the DVH comparison and distributed over the whole dose range.
In low-dose gradient regions, the difference between TPS1 and TPS2 was calculated as
for the dose released at a point by a single segment and by the total number of segments, respectively. Again, the local dose value was considered, for both measurements and calculation. In the high-dose gradient regions, we evaluated the difference in mm rather than using Eqs. (3) and (4). Two possible correlations were tested to assess the influence of the dose outside the segment in the different dose values calculated by the two systems:
1. A correlation between D TPS,tot at a point and the dose given by the segments that do not directly irradiate that point. If differences between TPS1 and TPS2 in calculation of the dose outside the segment are indeed the main cause of the differences in the total dose, this relation should show an increase of the differences for an increased importance of the dose given by segments that do not hit the point under analysis. 2. A correlation between D TPS,tot at a point and the value of the total dose in that point relative to the isocentre. Such a correlation can be used to assess whether differences in calculation of the dose outside the segment between TPS1 and TPS2 affect the various dose ranges in a different way.
Dose-volume parameters
The parameters used in the evaluation were: All these parameters were included in the cost function used in segment weight optimisation (see Appendix A).
Effect of dose differences on the optimisation process
As Jeraj et al. [15] have shown, the use of different dose calculation algorithms in IMRT optimisation can lead to two different kinds of discrepancies. On one hand, differences can arise by taking the solution proposed by one algorithm and re-evaluating it with a different one. We assessed this difference (which Jeraj defines as the systematic error) by recalculating in TPS2 the plans optimised in TPS1. On the other hand, discrepancies can be related also to different shapes of the solution space. In fact, the space of the possible solutions, being determined by both the dose calculation and the cost function, is in principle different when different dose calculation algorithms are used. We evaluated this component (which Jeraj defines as the convergence error) in two ways:
1. For the two patient categories, we assessed whether the differences in the dose calculation have an impact in the dose region where the cost function was defined; 2. For one patient with a head and neck tumour, we took the same segment definition and the same cost function in TPS1 and TPS2, but using their own dose calculation algorithms to optimise the segment weights. This test was intended to assess whether the differences between the two dose calculation algorithms are so large that different sets of segments would be required in the two systems to reach the plan objectives.
Results
Comparison of calculations with measurements in a water phantom
For the segments applied for IMRT of prostate and head and neck patients, D meas,i has a mean value of 0.7 and 0.6% for TPS1 and TPS2, respectively. All values of D meas,i are within 2.5%, except for a few segments that are either far off-axis (centre of the segment displaced by 5 cm or more in at least one direction) or very elongated. For these segments, the differences ranged from 3.0 to 15% for TPS1 and from 3.4 to 10% for TPS2. Comparison between measurements and calculation of the total dose distribution for a prostate treatment showed values of D meas,tot within 3 mm or 2% (for high and low-dose gradient regions, respectively) where the dose is higher than 35% of the prescribed dose (Fig. 1) . The calculations are for TPS1 and TPS2 on either side of the measurements; TPS1 is overestimating while TPS2 is underestimating the measured values. This means that, in the high-dose gradient region, D TPS,tot could in some points be as large as 5 mm. When the dose is lower than 35% of the dose at the isocentre, D meas,tot ranges from 10.5 to 15.5% for TPS1 and from 2 7 to 2 9.5% for TPS2.
For head and neck treatments, evaluation of both profiles of single segments and of the total dose at a point shows the same trend; the two systems give different estimates of the dose outside the geometric segment edge: TPS1 overestimates the dose and TPS2 underestimates it, with TPS2 somewhat closer to the measured values. For instance, a comparison of calculated and measured dose was carried out at a point for head and neck treatment geometry with 12 segments. This point was directly irradiated only by one segment, and its measured total dose was 22.6% of the dose at the isocentre. The total dose values calculated by TPS1 and TPS2 were 28.1 and 19.0% of the dose at the isocentre, respectively.
Comparison of CT-based plans
Comparison of dose calculations at selected points
The results presented in Fig. 2 show the correlation between D TPS,tot and the relative contribution of the dose outside the segment to the total dose at the point under analysis. The linear regression coefficient R 2 for the linear fit to this relation has a value of 0.92. For the prostate cases D TPS,tot is also correlated with the total dose (i.e. D TPS,tot increases for decreasing values of the total dose) while a weaker correlation has been found for the head and neck treatments. In the prostate plans, when the total dose is higher than 80% of the prescribed dose, either all segments directly irradiate the point under investigation or, in any case, the contribution from the fields not hitting the point is minimal. A point is in general outside all segments when its dose is lower than 15% of the prescribed dose (Table 1) .
Comparison of volumetric parameters
An example of the dose distribution characteristics for the IMRT plans calculated in TPS1 and TPS2 is given in Table 2 , for one prostate and one head and neck case. For all patients, the prostate results show good agreement for all parameters concerning the PTVs, i.e. the mean dose, V D95% of PTV2 and V D95% of PTV(1 -2). Concerning the rectal wall, for at least 4 out of 5 patients the differences in NTCP, V 75 Gy and V 70 Gy are smaller than 2%, while for three out of five patients the differences in V 45 Gy are larger than for the other rectal wall parameters, ranging from 0.8 to 9.2%. Except in one case, all values of V 45 Gy and V 65 Gy calculated by TPS1 are higher than those calculated by TPS2, while V 70 Gy and V 75 Gy values tend to be lower when calculated by TPS1. Fig. 3 shows a typical example of the DVHs calculated by the two systems for a prostate case.
For the head and neck cases, there are differences in the PTV dose distributions concerning in particular the mean dose (up to 4%), and, to a larger extent, V D90% (up to 22.1%). Except in one case, all V D95% , V D90% and mean values calculated by TPS2 are higher than those calculated by TPS1. A correlation was found between differences in mean dose and differences in V D90% . Concerning the parotid mean dose, TPS1 predicts in all cases higher values than TPS2; the mean difference is 2.1 Gy (range 1.0 -3.1 Gy). There is no correlation between the mean parotid dose and the differences between the values calculated by the two systems.
Effect of dose differences on the optimisation process
For our IMRT technique of prostate treatment, the differences between the two dose calculation algorithms appear for doses below 60 Gy for four out of five patients, while all plan objectives are related to dose values $ 65 Gy. This means that, using our cost function, the solution space calculated either by TPS1 or by TPS2 is essentially the same, and therefore the optimisation will converge to the same solution regardless the type of dose calculation algorithm. For head and neck cases, the results of the optimisation are influenced by the choice of the dose calculation algorithm. Because the differences occur both in the high and in the low-dose region, the two systems behave differently in the evaluation of the DVH points for the PTV and parotid mean dose, that are used as objectives for segment weight optimisation.
For the treatment plan where the dose distributions calculated by TPS1 and TPS2 were optimised with the same cost function, it was possible to achieve an equivalent PTV coverage with just a different distribution of the segment weights. The difference between the two solutions concerns the parotid, as TPS2 predicts a lower mean dose compared to TPS1 (21.1 vs. 23.8 Gy), but there was no need to add segments or to modify the shape of the existing segments to achieve the plan objectives. The first column indicates the segment number, the second the number of MUs associated with the segment, and then, for each of the three points, the contribution calculated by TPS1 and TPS2 and the position of the segment with respect to the point. Values are expressed as a percentage of the isocentre dose. I(in) represents a point inside the open part of the segment and O(out) a point under the leaves and/or the jaws. Distances between the field edge and the point less than 1 cm have been indicated. The DVH curves for the prostate patient are shown in Fig. 3 . Fig. 3 . DVHs of PTV2 and rectal wall for a prostate treatment plan. Triangles and circles indicate DVH points used in the computerized optimisation for rectal wall and PTV2, respectively.
Discussion
The implementation in clinical practice of complex treatment techniques like IMRT is strictly associated with the need for a dedicated QA programme of all phases of the treatment, from planning to delivery. Concerning the dose calculation, several studies have dealt with the problem of the accuracy needed for IMRT dose calculations in the presence of tissues inhomogeneities, emphasising the role of Monte Carlo-based codes, both in plan verification and during the optimisation process. Jeraj et al. [15] pointed out that the use of different dose calculations algorithms during fluence optimisation leads in principle to different solutions. These authors showed that an accurate dose calculation algorithm is needed for all phases of the optimisation and not only after the segmentation, in particular when the effect of tissue inhomogeneity is significant, like in lung treatments.
Although the accuracy in dose calculation might not always be so difficult to achieve as in lung, the IMRT treatment plans are still demanding for an accurate dose calculation algorithm, because the irradiation patterns are usually composed of many small and off-axis segments. In such a case, the dose calculation in the penumbra region as well as outside the segment becomes a critical issue. Azcona et al. [2] found that, without a correct tuning of the primary X-ray fluence through the jaws, the differences between measured and calculated dose in the high-dose region for a five-beam IMRT prostate treatment can be as high as 11.3%. They demonstrated in particular the importance of the socalled 'beam-fitting' process, i.e. the phase prior to TPS commissioning when the parameters that describe a model of the beam properties must be tuned in order to match the measured values in some selected geometries. In many cases the beam fit cannot lead to a perfect agreement between measurements and calculations for all situations. Trade-offs have to be made between different requirements that might slightly compromise the dose calculation in specific cases, but provide an overall good agreement for the wide spectrum of beam settings that are encountered in clinical practice. This does not mean that control of the accuracy of the dose calculation must not be strict. On the contrary, the overall performances of the dose calculation algorithm can still be defined with a rigorous method, e.g. using the concept of confidence limit, as suggested by Venselaar et al. [28] , but in a way that is compatible with the real practice, where many data points in comparable situations are taken into account.
Differences in single segments and point dose values
The two systems show a very different degree of agreement with the measurements depending on the position of the point under analysis with respect to segment edges. When a point is in the centre of the segment, even for off-axis or elongated segments, the calculated values of both TPS1 and TPS2 are in 95% of the cases within 3% of the measured value, which agrees with the tolerance proposed by two recent recommendations [13, 28] . On the other hand, when the point under analysis lies outside the segment edges, the differences increase by more than a factor of 10 and are in two cases larger than the proposed tolerance of 40% [28] of the local dose value or of 5% of the isocentre dose, as proposed by another report [13] . The differences between the two systems in this region are increased by the fact that they are on either side of the measured value; TPS1 overestimates the dose outside the segment, while TPS2 underestimates it. This can lead to differences as high as 50% for the points that are outside all segments (Fig. 2) .
Comparison of 3D dose distributions in CT-based plans
The IMRT plans analysed in our study can be considered, with respect to segment setting, as an intermediate between conventional 3D-CRT plans and IMRT plans where a large number of segments, or a dynamic MLC approach, is applied to produce highly modulated intensity patterns. In prostate treatments, for instance, the vast majority of the points belonging to the boost volume are irradiated by all segments, while the points belonging to the rectal wall are mostly close to the segment edge or below the MLC leaves, as in a 3D-CRT treatment. Therefore, for such a site, an accurate dose calculation outside the segment edge is much more important for the organ at risk than for the target volume. On the other hand, the PTV in treatments of the head and neck region requires a different approach due to the complexity of the patient anatomy, and a number of segments only irradiate parts of the PTV. As a consequence, the dose coming from the regions outside segment edges contributes also to the total dose of the PTV. Because of these different irradiation geometries, the differences between TPS1 and TPS2 in head and neck PTV mean dose values are larger than for prostate treatments. The differences in V D90% are in some cases quite dramatic, being as high as 20%. On the other hand, there is a correlation between differences in V D90% and the differences in mean dose, thus suggesting that, if the two DVHs were normalized to the same mean dose, the differences in V D90% would be smaller. Furthermore, the DVH curves are very steep in this dose region, and therefore small shifts in dose translate into large shifts in volumes. Therefore, the primary cause of the differences between the values of V D90% is the different mean dose value calculated by the two systems rather than a difference in the shape of DVH curves.
The comparison of DVHs for OARs shows a common behaviour in both prostate and head and neck treatments. If the dose is lower than 75 -80% of the prescribed dose, TPS1 systematically overestimates the dose compared to TPS2, while for doses higher than 80% the dose values calculated with the two systems have much better agreement. This effect is due to an increasing importance of the dose outside the segment for decreasing values of total dose, for prostate plans in particular.
The point dose measurements in combination with the limited number of line scans performed in this study do not allow accurate assessment of a measured volumetric dose distribution of PTV or OAR. Although the water phantom measurements, as given for instance in Fig. 1 , suggest that the actual DVH curve will lie between those calculated by TPS1 and TPS2, no measured data are currently available. Such data can be obtained by irradiating a stack of radiographic films in a suitable solid phantom. Another possibility might be to validate the full 3D dose distribution calculated with clinically applied TPS with Monte Carlo calculations, assuming that the latter compute dose distributions accurately.
Effects of dosimetric differences on plan optimisation
The effect of dosimetric differences on plan optimisation is the result of the combination of two elements: the dose differences themselves and the characteristics of the cost function. As a consequence, differences in dose calculation will have different effects on the optimisation process for PTV and OARs and for prostate and head and neck treatments.
PTVs
The cost functions used in prostate and head and neck optimisation are similar for the PTV, as the plan objectives for both sites concern PTV coverage, mean dose and maximum dose. Nevertheless, for prostate optimisation the effect of the dose outside the segment is negligible, while it is important in head and neck optimisation. Consequently, for head and neck treatments the choice of the dose calculation algorithm will affect the optimisation outcome.
OARs
Although the differences in DVH curves show a common behaviour for the rectal wall and for the parotids, the optimisation of plans is affected by those differences only for the head and neck treatment. This is due to the different characteristics of the cost function. For prostate, the clinical data which form the basis of the currently applied cost function suggest that rectal wall side effects are only related to dose values higher than 60 Gy [3] . This value corresponds to about 77% of the prescribed dose, and therefore all plan objectives are in a dose range where the two algorithms have good agreement. This is also the explanation of the small differences found in NTCP values. In fact, in the current NTCP model, the value of the n parameter is quite small ðn ¼ 0:12Þ; and therefore the NTCP value is much more sensitive to the high-dose region, where the two systems are in good agreement, than to the dose values where differences were found. However, there is emerging evidence that also doses between 40 and 50 Gy are correlated with damage to the rectum related to side effects [12, 26] . If this is the case, then the cost function used in prostate optimisation has to be redesigned. As a consequence, the optimisation of prostate plans will also be affected by the differences in dose calculation outside the segment edge.
For salivary glands, late effects are correlated to the parotid mean dose, a parameter that is affected by low-dose values, and therefore different values of the dose outside the segment affect the results of the optimisation process.
Applicability to IMRT of dose accuracy tolerances valid for CRT
According to the experimental tests we performed and the tolerances for the accuracy of dose calculation proposed by various reports, TPS1 and TPS2 can both be considered suitable for clinical use. On the other hand, the results obtained suggest that, as far as the dose calculation outside the segment edges is concerned, IMRT treatments require a different approach with respect to accuracy compared to CRT.
Deriving recommendations for tolerances for the accuracy of dose calculation for IMRT in general, or even for the cases discussed in this paper, is a complex problem. First, the method presented in our study has to be modified to be suitable for defining such recommendations, as one would need to repeat for several situations the kind of point measurements relative to the whole treatment as described in section 3.1. The points analysed in our comparison (Fig.  2 ) cannot be randomly distributed in an irradiated volume. In fact, they must have some specific properties, like covering the whole dose range, and, more important, being in a proper position with respect to all segments, i.e. as much as possible either in the open part or completely outside the segment, but not in the penumbra. Combining these requirements with the difference in geometry between a phantom and a patient and the limited number of ionisation chamber positions, we end up with a situation where performing a sufficiently large number of measurements is impractical. A realistic alternative would be to make a treatment plan directly for a phantom irradiation, thus taking into account these geometrical constraints from the beginning. Furthermore, the validity of a general statement about the required accuracy will be limited because IMRT techniques can be very different in terms of degree of modulation and delivery method. Experimental assessment of the 3D dose distribution for every single IMRT technique is probably at this moment the best approach. If such a task could not be accomplished, at least a proper combination of point, 1D and 2D dose measurements should be devised, making sure that such a procedure allows an accurate determination of the dose distribution over the whole dose range in a 3D volume of interest. For example, if the issue under analysis is the dose outside the segment edges, it is very important to properly sample the middle to low-dose region. As a consequence, it is possible that orthogonal scan lines in the AP, LR and HF directions crossing each other at the isocentre are not providing the desired information and that one should choose to scan the dose distribution in areas more peripheral with respect to the center of the target.
Conclusion
In the commissioning of a TPS for IMRT treatments, the accuracy of the calculation of the dose outside the segment is of major concern, also when the degree of modulation and the number of segments are not extremely high. Even for relatively simple IMRT techniques, the fulfilment of accuracy requirements for dose calculations valid for CRT is not adequate. 1D and 2D tests are no longer sufficient to appreciate the differences between measurements and calculation, and the complete 3D dose distribution delivered to the patient should be evaluated. In the definition of cost functions for IMRT, the choice of the plan objectives has to be carried out with knowledge of the effects of dose calculation accuracy on the optimisation outcome. 
